Nektar Therapeutics
NKTR
30.20
-2.34
-7.19%
Nektar Therapeutics
US · NKTR
#3017 by market cap
Listed 1970
30.20
-2.34
-7.19%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Nektar Therapeutics
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.
- Founded
- 1990
- CEO
- Mr. Howard W. Robin
- Employees
- 63
- Headquarters
- San Francisco, California, United States of America
- Fiscal year end
- 12-31
- Website
- nektar.com
Company profile
- Exchange
- US
- Symbol
- NKTR
- Market-cap rank
- #3017
- Listing date
- 1970-01-01
- Market cap
- 1.03B
- Float cap
- 864.00M
- Shares out
- 34.21M
- Float shares
- 28.61M
Sectors & themes
Quote time 2026-11-20 20:02:35 · For reference only, not investment advice and not tailored to your situation.
Nektar Therapeutics discussion 0 comments